Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide in Patients With Dumping Syndrome
NCT01895296Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Sep 2008
- Primary completion
- Jan 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pasireotide LAR in dumping syndrome, sponsored by UZ Leuven. Started Sep 2008; status: completed.
02
Drugs
pasireotide LAR
03
Conditions
dumping syndrome
Beyond the preview
Go deeper on NCT01895296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01895296.